Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Urologic Neoplasms 1Stomach Neoplasms 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 260fludarabine phosphate 163Methotrexate 124Rituximab 112Cytarabine 109Filgrastim 106fludarabine 92Busulfan 86Peripheral Blood Stem Cell Transplantation 83Etoposide 82Vincristine 80Radiotherapy 79Tacrolimus 73Mycophenolic Acid 72Antilymphocyte Serum 68Whole-Body Irradiation 66Melphalan 63Dexamethasone 63Cyclosporine 58Doxorubicin 51Prednisone 44Methylprednisolone 44Alemtuzumab 44Mercaptopurine 41Granulocyte Colony-Stimulating Factor 40pegaspargase 35Daunorubicin 34Clofarabine 33Thiotepa 31Asparaginase 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Tissue Banks × Lymphoid × Clear all
NCT06827639 2025-02-14

FUTURE

Assistance Publique Hopitaux De Marseille

Not yet recruiting
640 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Head and Neck Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Stomach Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡